The prognostic value of CXC-chemokine receptor 2 (CXCR2) in gastric cancer patients

Overview of attention for article published in BMC Cancer, October 2015

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 31 Dimensions

Readers on

mendeley: 24 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 31 publications that cite this research output.

31

The most recent citing publications are shown below. View all 31 publications that cite this research output on Dimensions.

Clinicopathological significance of microsatellite instability and immune escape mechanism in patients with gastric solid-type poorly differentiated adenocarcinoma

Article in Gastric Cancer (March 2024)

CXCR2 inhibition overcomes ponatinib intolerance by eradicating chronic myeloid leukemic stem cells through PI3K/Akt/mTOR and dipeptidylpeptidase Ⅳ (CD26)

Article in Heliyon (November 2023)

Therapeutic inhibition of CXCR1/2: where do we stand?

Article in Internal and Emergency Medicine (May 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.